An A1c test measures the percentage of your hemoglobin (the oxygen-carrying protein in red blood cells) that has glucose attached to it. The test requires a blood sample, either from a standard blood draw or a finger stick, and no fasting or special preparation is needed beforehand. Because glucose bonds to hemoglobin gradually over a red blood cell’s 120-day lifespan, the result reflects your average blood sugar over roughly two to three months.
How Glucose Bonds to Hemoglobin
Glucose in your bloodstream slowly attaches to the ends of hemoglobin’s beta chains through a natural, non-enzymatic chemical reaction. This process happens continuously: the more glucose circulating in your blood, the more hemoglobin gets “glycated.” The bond is essentially permanent for the life of that red blood cell.
Red blood cells live about 120 days before your body replaces them. At any given moment, your blood contains a mix of younger and older red blood cells, each carrying a record of the glucose levels they were exposed to. Research tracking this process found that the glucose-labeled hemoglobin accumulates steadily, reaching its full proportion by around day 60. This is why the A1c result is weighted more heavily toward the most recent four to six weeks rather than being a perfectly even average of the full three months.
What Happens in the Lab
When your blood sample reaches the laboratory, technicians use one of several methods to separate glycated hemoglobin from the rest and calculate what percentage it represents. The three most common approaches each work differently.
- Ion exchange chromatography separates hemoglobin types based on their electrical charge. Glycated hemoglobin carries a slightly different charge than regular hemoglobin, so it moves through the testing column at a different speed. This method is highly precise and is the basis for the original reference standard.
- Boronate affinity uses a chemical that binds specifically to the glucose attached to hemoglobin. It’s less prone to interference from hemoglobin variants, making it a good choice for patients with conditions like sickle cell trait.
- Immunoassay uses antibodies designed to recognize the specific spot where glucose attaches to hemoglobin. This method is relatively easy to implement across different testing platforms and isn’t affected by several common hemoglobin variants.
Each method has trade-offs in precision and susceptibility to interference, but all certified methods should produce comparable results thanks to a rigorous standardization system.
How Labs Keep Results Consistent
If you get your A1c tested at two different labs, the results should be nearly identical. That consistency exists because of the National Glycohemoglobin Standardization Program (NGSP), established in 1996 to ensure that every lab’s A1c results are traceable to the same reference standard used in the landmark clinical trials that defined diabetes treatment targets.
The system works through a network of reference laboratories. A central reference lab maintains the gold-standard measurement method. Secondary reference labs use commercial methods calibrated to match that central lab, and all are monitored monthly with blinded blood samples. Manufacturers earn a one-year certificate of traceability by running 40 blinded samples and demonstrating that their results fall within tight accuracy limits. Routine clinical labs are then surveyed through proficiency testing programs to make sure accuracy holds up in everyday practice.
Point-of-Care Testing vs. Lab Testing
Many doctor’s offices now offer rapid A1c results from a finger-stick sample, giving you a number in minutes rather than days. These point-of-care devices are convenient, but they’re measurably less accurate than full laboratory testing. A 2017 review of 61 studies comparing 13 point-of-care devices to lab methods found that every single device showed some degree of bias, with results skewing either higher or lower than the lab value. Several devices also showed inconsistent results between different batches of test strips.
For this reason, the American Diabetes Association recommends that A1c tests used for diagnosing diabetes be performed in an accredited laboratory, not on a point-of-care device. Office-based finger-stick testing is still useful for routine monitoring, particularly for children or pregnant patients where a quick finger stick is preferable to a full blood draw. But if a point-of-care result leads to a major treatment decision, confirming with a laboratory test is a reasonable step.
When A1c Results Can Be Misleading
Because the test depends on hemoglobin behaving in a predictable way, anything that changes your hemoglobin or your red blood cell lifespan can throw off the result.
Hemoglobin variants are one common source of interference. Hundreds of variants exist, but four are most relevant: hemoglobin S (sickle cell), hemoglobin C, hemoglobin D, and hemoglobin E. These altered forms of hemoglobin can produce falsely high or falsely low A1c readings depending on which lab method is used. Elevated fetal hemoglobin, which some adults carry in small amounts, can also interfere with certain testing platforms.
Conditions that shorten or lengthen red blood cell lifespan affect results in a different way. Iron-deficiency anemia, for example, can cause red blood cells to live longer than usual, meaning more glucose accumulates on each cell and the A1c reads higher than your actual average blood sugar. Conversely, conditions that destroy red blood cells faster, like sickle cell disease, significant kidney disease, or liver failure, can produce a falsely low A1c because the cells don’t live long enough to accumulate their expected share of glucose. In these situations, your doctor may rely on alternative measures of blood sugar control.
What the Numbers Mean
An A1c below 5.7% is considered normal. A result between 5.7% and 6.4% falls in the prediabetes range, indicating higher-than-normal blood sugar that hasn’t yet reached the diabetes threshold. An A1c of 6.5% or higher, confirmed on a repeat test, meets the diagnostic criteria for diabetes.
To make these percentages more intuitive, labs often report an estimated average glucose (eAG) alongside the A1c. The conversion formula is straightforward: multiply the A1c by 28.7, then subtract 46.7. An A1c of 7%, for instance, translates to an estimated average blood sugar of about 154 mg/dL. This number represents a true 24-hour average, capturing overnight lows and post-meal spikes that a single fasting glucose test would miss.